Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

SciClone Pharmaceuticals Company Profile (NASDAQ:SCLN)

Consensus Ratings for SciClone Pharmaceuticals (NASDAQ:SCLN) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $9.00 (3.69% upside)

Analysts' Ratings History for SciClone Pharmaceuticals (NASDAQ:SCLN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/19/2014AegisSet Price TargetBuy$10.00ViewTweet This Rating  Share This Rating on StockTwits
11/14/2014BWS FinancialDowngradeBuy -> Hold$8.25 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
8/29/2014AegisReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
11/12/2013AegisLower Price TargetBuy$9.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
9/25/2013AegisReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
8/9/2013TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
7/16/2013AegisUpgradeHold -> Buy$9.00ViewTweet This Rating  Share This Rating on StockTwits
2/25/2013AegisDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/22/2012 forward)